Maria Monica Gramatges, MD, PhD
- Texas Medical Center
- Developmental therapeutics
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|Stanford University School of Medicine||fellowship||Pediatric Hematology Oncology||2009|
|Oregon Health Sciences University||residency||Pediatrics||2006|
|University of Texas at Houston||medical school||Doctor of Medicine||2003|
|Baylor Graduate School of Biomedical Sciences||university||Doctor of Philosophy, Clinical Investigation||2015|
Dr. Maria Monica Gramatges is a member of the of the Cancer Genetics and Genomics Program, the Leukemia Program, and the Long Term Survivor Program at Texas Children's Cancer Center. Her clinical interests include leukemia, cancer survivorship, and outcome disparities. She is board certified by the American Board of Pediatrics-Hematology/Oncology.
|American Society for Pediatric Hematology/Oncology (ASPHO)||Member|
|American Society of Hematology (ASH)||Member|
|Children's Oncology Group (COG)||Member|
Dr. Gramatges is Co-Director of the Survivorship Research Program at Texas Children’s Cancer and Hematology Centers. The objectives of the Gramatges lab are to uncover genetic risks, such as underlying defects in telomere maintenance, that may predispose children to cancer and cancer therapy-related toxicities as well as late effects. Her research explores these associations using human samples obtained locally and in collaboration with organizations such as the Children’s Oncology Group and the Childhood Cancer Survivor Study. Of particular interest to her lab are biomarkers of aging and frailty, and how these biological factors are related to features of premature, accelerated aging observed in survivors of childhood cancer.
Texas Children's Hospital pediatric cancer doctor receives $300K in Hyundai grant (Houston Chronicle - September 28, 2018)